What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Enzyme
Jason S. Lewis focuses on Positron emission tomography, In vivo, Nuclear medicine, Pathology and Biodistribution.
His Positron emission tomography study combines topics from a wide range of disciplines, such as Cancer, Tumor hypoxia, Radiation therapy, Hypoxia and Medical physics.
His studies in In vivo integrate themes in fields like Radiochemistry, In vitro, Biochemistry and Gene expression.
He has included themes like Antibodies monoclonal, Molecular targets, Tomography, Octreotide and Copper-64 in his Nuclear medicine study.
His Pathology research is multidisciplinary, relying on both Cell culture, Pharmacokinetics, Limiting oxygen concentration, Cancer research and Cell.
His Biodistribution research incorporates elements of Ex vivo, Distribution, Transplantation and Ratón.
His most cited work include:
- Superparamagnetic iron oxide: Pharmacokinetics and toxicity (869 citations)
- Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy (505 citations)
- Imaging biomarker roadmap for cancer studies. (407 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Cancer research, In vivo, Nuclear medicine, Biodistribution and Positron emission tomography.
His Cancer research study also includes fields such as
- Cancer that connect with fields like Oncology,
- Prostate cancer that connect with fields like Prostate.
His research integrates issues of Pretargeting, In vitro, Pharmacology and Pathology in his study of In vivo.
His Nuclear medicine research incorporates themes from Lesion and Radiation therapy.
Jason S. Lewis interconnects Ex vivo, Pharmacokinetics, Imaging agent, Molecular biology and Kidney in the investigation of issues within Biodistribution.
His Positron emission tomography research is multidisciplinary, incorporating elements of Molecular imaging and Hypoxia.
He most often published in these fields:
- Cancer research (27.46%)
- In vivo (27.46%)
- Nuclear medicine (25.25%)
What were the highlights of his more recent work (between 2018-2021)?
- Cancer research (27.46%)
- In vivo (27.46%)
- Biodistribution (23.73%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Cancer research, In vivo, Biodistribution, Nuclear medicine and Cancer.
His Cancer research study incorporates themes from In vitro, Pancreatic cancer, Radioimmunotherapy, Receptor and Antibody.
His Biodistribution study also includes
- Ex vivo and related Positron emission tomography and Tumor microenvironment,
- Toxicity together with Salivary gland and Peptide,
- Specific activity that connect with fields like Pharmacology.
As a member of one scientific family, Jason S. Lewis mostly works in the field of Positron emission tomography, focusing on Molecular imaging and, on occasion, Medical physics.
His study looks at the intersection of Nuclear medicine and topics like Lesion with Lymph.
His Cancer research integrates issues from Imaging agent and Oncology.
Between 2018 and 2021, his most popular works were:
- First-in-Humans Imaging with 89Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting (49 citations)
- EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer (42 citations)
- Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis (31 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Enzyme
His primary areas of investigation include Cancer research, Biodistribution, Nuclear medicine, In vivo and Positron emission tomography.
His Cancer research research includes elements of Cancer, In vitro, Trastuzumab and Tyrosine kinase, Receptor.
His work deals with themes such as Ex vivo, Pharmacokinetics, Therapeutic index, Somatostatin and Bone marrow, which intersect with Biodistribution.
His research investigates the connection between Nuclear medicine and topics such as Radioimmunotherapy that intersect with problems in Ommaya reservoir, Cerebrospinal fluid and Malignancy.
The study incorporates disciplines such as Cancer cell, Malignant Growth, Membrane insertion, Pertuzumab and Dark quencher in addition to In vivo.
While the research belongs to areas of Positron emission tomography, Jason S. Lewis spends his time largely on the problem of Magnetic resonance imaging, intersecting his research to questions surrounding Molecular imaging, Liposome and Vascular permeability.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
